Gilead Sciences, Inc. (GILD) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 7 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
t872287t t872287t 04/04/2014 3 months $73.98 $70.00 -5.38% -5 Active
Comments:
Malith Malith 02/25/2014 3 months $83.95 $70.00 -16.62% -16 Active
Comments: Invented a medication for Hep C
Joward Joward 02/25/2014 1 Year $83.77 $70.00 -16.44% -16 Active
Comments:
villanueva villanueva 02/22/2014 1 Year $82.59 $70.00 -15.24% -15 Active
Comments:
markrefuerzo markrefuerzo 02/22/2014 1 Year $82.59 $70.00 -15.24% -15 Active
Comments:
backafterthebreak backafterthebreak 02/20/2014 1 Year $82.70 $70.00 -15.36% -15 Active
Comments:
floydc floydc 01/31/2014 1 Year $81.38 $70.00 -13.99% -13 Active
Comments:
Jack of all Trades Jack of all Trades 12/21/2013 3 months $74.66 $76.54 +2.52% 2 Ended
Comments: Biotech Leader, industry leader ... Read the full entry
Jhonnyk Jhonnyk 01/03/2013 1 Year $75.06 $75.21 +0.2% 1 Ended
Comments: HIV been approved, Hepitits C will b till mid/end of 2013=HUGE revenue growth and great upside
JOKER66 JOKER66 10/24/2012 3 months $64.91 $78.29 +20.61% 20 Ended
Comments:
ArinzeRobert ArinzeRobert 05/14/2012 1 month $52.46 $49.12 -6.38% -6 Ended
Comments: Upcoming product launch will be successful
OMARI OMARI 05/14/2012 3 months $52.64 $56.77 +7.85% 7 Ended
Comments: Industry sector growing or poised for growth
Arnaud_1 Arnaud_1 02/15/2011 3 months $38.93 $53.76 +38.09% 38 Ended
Comments: This is a well managed company

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.